Detalhe da pesquisa
1.
Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses.
Sci Transl Med
; 14(636): eabg8402, 2022 03 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-35294258
2.
IL-7 expands lymphocyte populations and enhances immune responses to sipuleucel-T in patients with metastatic castration-resistant prostate cancer (mCRPC).
J Immunother Cancer
; 9(8)2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34452927
3.
Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer.
Clin Cancer Res
; 27(16): 4574-4586, 2021 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34112709
4.
Assessment of the Safety of Pembrolizumab in Patients With HIV and Advanced Cancer-A Phase 1 Study.
JAMA Oncol
; 5(9): 1332-1339, 2019 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31154457
5.
Phase I Trial of ALT-803, A Novel Recombinant IL15 Complex, in Patients with Advanced Solid Tumors.
Clin Cancer Res
; 24(22): 5552-5561, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30045932
6.
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors.
Clin Cancer Res
; 24(7): 1525-1535, 2018 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29203590